Laurion Capital Management LP Natera, Inc. Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $464,388 - $585,804	-4,636 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $398,927 - $555,021	4,636 New	4,636 $526,000
Q4 2020 Feb 12, 2021	SELL	$66.66 - $111.74 $999,900 - $1.68 Million	-15,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$45.89 - $72.67 $276,808 - $438,345	-6,032 Reduced 28.68%	15,000 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $177,455 - $335,657	6,732 Added 47.08%	21,032 $1.05 Million
Q1 2020 May 14, 2020	BUY	$17.27 - $40.17 $246,961 - $574,431	14,300 New	14,300 $427,000
Q4 2019 Feb 13, 2020	SELL	$32.1 - $40.4 $831,390 - $1.05 Million	-25,900 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$25.38 - $34.89 $673,610 - $926,015	-26,541 Reduced 50.61%	25,900 $850,000
Q2 2019 Aug 13, 2019	BUY	$17.75 - $27.58 $930,827 - $1.45 Million	52,441 New	52,441 $1.45 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.